We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Can Youthful Mesenchymal Stem Cells from Wharton's Jelly Bring a Breath of Fresh Air for COPD?
- Authors
Janczewski, Andrzej M.; Wojtkiewicz, Joanna; Malinowska, Ewa; Doboszyńska, Anna
- Abstract
Chronic obstructive pulmonary disease (COPD) is a major global cause of morbidity and mortality, projected to become the 3rd cause of disease mortality worldwide by 2020. COPD is characterized by persistent and not fully reversible airflow limitation that is usually progressive and is associated with an abnormal chronic inflammatory response of the lung to noxious agents including cigarette smoke. Currently available therapeutic strategies aim to ease COPD symptoms but cannot prevent its progress or regenerate physiological lung structure or function. The urgently needed new approaches for the treatment of COPD include stem cell therapies among which transplantation of mesenchymal stem cells derived from Wharton's jelly (WJ-MSCs) emerges as a promising therapeutic strategy because of the unique properties of these cells. The present review discusses the main biological properties of WJ-MSCs pertinent to their potential application for the treatment of COPD in the context of COPD pathomechanisms with emphasis on chronic immune inflammatory processes that play key roles in the development and progression of COPD.
- Subjects
OBSTRUCTIVE lung diseases; MORTALITY; MESENCHYMAL stem cells; INFLAMMATION; ANTI-inflammatory agents
- Publication
International Journal of Molecular Sciences, 2017, Vol 18, Issue 11, p2449
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms18112449